p53 immunostaining in differential diagnosis of pleural mesothelial proliferations

Anticancer Research

Volumn 17, Issue 1 B, 1997, Pages 733-736

  Esposito, Vincenzo ^a,b   Baldi, Alfonso ^a   De Luca, Antonio ^a   Claudio, Pier Paolo ^a   Signoriello, Giuseppe ^b   Bolognese, Angela ^a   Centonze, Paola ^a   Giordano, Giovan Giacomo ^b   Caputi, Mario ^b   Baldi, Feliciano ^b   Giordano, Antonio ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Mesothelioma; p53 immunohistochemistry; Survival

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; HYPERPLASIA; MAJOR CLINICAL STUDY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; HUMANS; MESOTHELIOMA; MIDDLE AGED; NEOPLASM PROTEINS; PLEURAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031044559     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cote R J, Jhanwar SC, Novick S, Pellicer A: Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. Cancer Res 51: 5410-5416 1991.
2. Ebina M, Steimberg SM, Mulshine JL, Linnoila RI: Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non small cell lung cancer. Cancer Res 54: 2496-2503, 1994.
3. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Canc Res 54: 4855-4878, 1994.
4. Hollstein M, Sidransky D, Vogelstein B, Harris C: p53 mutations in human cancers. Science 253: 49-53, 1991.
5. Iggo R, Gatter K, Bartek J, Lane D, Harris A L: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335: 675-679, 1990.
6. Kafiri G, Thomas DM, Shepherd NA, Krausz T, Lane DP, Hall PA: p53. expression is common in malignant mesothelioma. Histopathology 21: 331-334, 1992.
7. Korkolopoulou P, Oates J, Crocker J, Edwards G: p53 expression in oat and non oat small cell lung carcinomas: correlation with proliferating cell nuclear antigen. J Clin Pathol 40: 1093-1096, 1993.
8. Levine AJ: The tumor suppressor genes. Ann Rev Biochem 62: 623-651, 1993.
9. Mayall FG, Goddard H, Gibbs AR: p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin fixed paraffin sections. J Pathol 168: 377-381, 1982.
10. Ramael M, Lemmens G, Eedekens C, Buysse C, Deblier I, Jacobs W, Van Mark E: Immunoreactivity for p53 protein in malignant mesothelioma and non neoplastic mesothelium. J Pathol 168: 371-375 1992.
11. Sang N, Baldi A, Giordano A: The roles of tumor suppressors pRb and p53 in cell proliferation and cancer. Mol and Cell Differ 3: 1-29, 1995.
12. Wang EH, Friedman PS, Prives C: The murine p53 protein blocks replication of SV 40 DNA in vitro by inhibiting the initiation functions of SV 40 large antigen. Cell 28: 387-394, 1990.
13. Werness BA, Levine AJ, Howley PM: Association of human apillomavirus types 16 and 18 E6 proteins withh p53. Science 248: 444-452, 1990.
14. Cicala C, Pompetti F, Carbone M: SV40 induces mesotheliomas in hamsters. Am J Pathol 142: 1524-1533, 1993.
15. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJ, Levine AS, Procopio A: Simian Virus 40 -like DNA sequences in human pleural mesothelioma. Oncogene 9: 1781-1790 1994.
16. Metcalf RA, Welsh JA, Bennett WP, Lehman TA, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Gerwin BJ, Harris CC: p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res 52: 2610-2615 1992.